Xap Therapeutics Limited (Companies House Registration Number 10613866) is a private limited company started on 2017-02-10 originating in United Kingdom. The firm is registered at Babraham Research Campus, Maia Building (B270), Cambridge CB22 3AT. Having undergone a change in 2021-07-20, the previous name this company used was Rockend Limited. Xap Therapeutics Limited operates Standard Industrial Classification: 64303 - "activities of venture and development capital companies".

Company details

Name Xap Therapeutics Limited
Number 10613866
Date of Incorporation: February 10, 2017
End of financial year: 31 December
Address: Babraham Research Campus, Maia Building (b270), Cambridge, CB22 3AT
SIC code: 64303 - Activities of venture and development capital companies

Moving on to the 4 directors that can be found in this business, we can name: Rodger N. (in the company from 27 April 2020), Simeon G. (appointment date: 05 September 2017), Matthew F. (appointed on 05 September 2017). 1 secretary is also present: Josephine S. (appointed on 19 July 2022). The official register reports 3 persons of significant control, namely: Shaun F. owns 1/2 or less of shares, Rodger N. owns 1/2 or less of shares, Glaxosmithkline Finance Plc can be reached at Great West Road, TW8 9GS Brentford, Middlesex. This corporate PSC owns 1/2 or less of shares, 1/2 or less of voting rights.

Directors

Accounts data

Date of Accounts 2018-02-28 2019-02-28 2019-12-31
Current Assets 208,378 189,042 232,841
Total Assets Less Current Liabilities 202,180 156,144 172,971

People with significant control

Shaun F.
10 February 2017 - 19 April 2021
Nature of control: 25-50% shares
Rodger N.
28 April 2020 - 19 April 2021
Nature of control: 25-50% shares
Glaxosmithkline Finance Plc
29 July 2020 - 17 September 2020
Address 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Legal authority United Kingdom (England And Wales)
Legal form Public Limited Company
Country registered England And Wales
Place registered Companies House
Registration number 00242686
Nature of control: 25-50% voting rights
25-50% shares

Filings

Categories:
Accounts Address Capital Confirmation statement Incorporation Mortgage Officers Persons with significant control Resolution
(SH01) Statement of Capital on 7th January 2024: 63.05 GBP
filed on: 28th, January 2024 | capital
Free Download (4 pages)